COPYKITTEN

CopyKitten understands how important it is to eradicate counterfeits from the market and we believe, you know it too. With this video, you’ll learn ‘how to download the CopyKitten App’ from the official android playstore and report infringements. With the help of seamless technology, CopyKitten makes the process of detection, comparison and action instantaneous. And gives your brand a well sorted way to protect its presence. . . Follow COPYKITTEN and help us identify the fake 🙌🏻 #DemocratizingBrandProtection . . . #copykitten #copykittenair #ipr #intellectualproperty #brandprotectiontip #corporatelaw #brandprotection #indianlawyers #indianstartup #techlovers #sodelhi #delhibased #copyright #lawyer #branding #brandenforcement #brandregistration #counterfeit #duplicate #indianlaw #indianlawupdates #lawfirmsocial #reelitfeelit #reelkarofeelkaro #reelsinstagram #explorepage #trendingreels

The Legacy of Lipitor: Navigating Innovation and Competition in Pharmaceuticals 💡🚀 In the annals of pharmaceutical history, few drugs have left as profound a mark as Lipitor. Developed by Pfizer in the early 2000s, Lipitor revolutionized the treatment of high cholesterol, becoming one of the best-selling medications of all time. As Lipitor's patent expiration loomed, Pfizer faced a pivotal moment: how to maintain its market dominance in the face of impending generic competition. The company devised a multifaceted strategy, including aggressive marketing campaigns, price adjustments, and legal maneuvers, to prolong Lipitor's reign. One key aspect of Pfizer's strategy was the development of Lipitor XR, an extended-release formulation aimed at extending patent protection. Additionally, Pfizer engaged in patent litigation to defend its intellectual property rights and delay generic competitors' entry into the market. Despite Pfizer's efforts, Lipitor eventually faced generic competition as its patent expired in 2011. Yet, Lipitor's legacy endures as a testament to the power of pharmaceutical innovation and the challenges of navigating the transition from patented blockbusters to generic alternatives. The story of #Lipitor reminds us of the intricate dance between innovation and competition in the pharmaceutical industry. It underscores the strategic dilemmas faced by companies as they balance the pursuit of profits with the imperative of advancing public health. If you're facing issues and want to safeguard your brand from #IP Theft, COPYKITTEN and InstaQuest Consulting Pvt. Ltd. have all the solutions for you. Reach us out to know more 💊🌐 . . . #PharmaceuticalInnovation #IntellectualProperty #CompetitionInTheMarket Kanchan Lele Vincent Jose #Pfizer #Atorvastatin #IPR #Pharma #Pharmaceuticals #Corporatelawyer #indianlaw #medicine

Happy Holi to all ! May this festival of colors fill your life with joy, prosperity, and vibrant moments shared with loved ones. Let's embrace the spirit of unity and renewal as we welcome the arrival of spring. #HappyHoli #FestivalOfColors #copykitten 🎨🌈

Fuel your business's growth! Learn how to leverage intellectual property with 4 proven strategies for accelerated success and maintaining a competitive edge 💯✅ . . Follow COPYKITTEN We make informational content like this 🙌🏻 . . . #copykitten #ipr #intellectualproperty Kanchan Lele #trademark #copyright #patent #innovation #brandprotection #indianlawyer #techapp #growthhacking

Did you know? Band-Aid is a registered trademark of Johnson & Johnson for their brand of adhesive bandages. First invented in 1920, Band-Aids have become synonymous with wound care and are widely recognized for their convenience and effectiveness. Band-Aid is an example of a brand that has become a victim of genericide, as many people use the term "Band-Aid" to refer to any adhesive bandage, regardless of whether it is actually a Band-Aid brand product. This phenomenon can occur when a brand becomes so dominant in the market that it becomes synonymous with the product category, leading to the brand name being used as a common term. Follow COPYKITTEN 🙌🏻 . . . . #copykitten #brandabuse #brandidentity #ipr #doctor #injury #doctorlife #intellectualproperty #copyright Kanchan Lele #johnsonandjohnson #bandaid

Balancing Innovation and Protection: India's Intellectual Property Landscape 💼🔒 Indian Finance Minister, Nirmala Sitharaman highlighted India's dynamic approach to intellectual property rights ( #IPR ), emphasizing a delicate balance between protecting innovators and stimulating research and development (R&D) talent. The recent push for robust IPR laws reflects the nation's commitment to fostering innovation while safeguarding commercial interests. Key initiatives, including the 2016 PR Policy and streamlined patent granting processes, underscore India's dedication to facilitating R&D activities. Notably, efforts to reduce fees for startups, MSMEs, and educational institutions demonstrate a commitment to inclusivity in the innovation ecosystem. Sitharaman outlined the comprehensive legislative framework, aligning with Trade-Related Aspects of Intellectual Property Rights (TRIPS) while addressing development concerns. The consolidation of various IPR categories under one umbrella enhances efficiency, streamlining processes for applicants. India's strides in academia and research are further bolstered by schemes promoting holistic education in IPRs. Additionally, the collaborative efforts of the Delhi High Court, led by Justice Pratibha Singh, exemplify the judiciary's role in expediting IPR matters and clearing backlogs. As India navigates its intellectual property landscape, the message is clear: fostering innovation requires a strategic blend of protection, accessibility, and efficiency. Let's continue to empower innovators and drive sustainable development through robust IPR frameworks. 🌐💬 #intellectualproperty Kanchan Lele #indianlaw #financeminister #nirmalasitharaman #patent #copyright #trademark #rnd #innovation

The Risks of Patent Exploitation in Drug Manufacturing: A Cautionary Tale 💉🔍 While the idea of making patented drugs available for generic use at cheaper prices may seem like a win-win scenario, the reality is far more complex. Here's why: 1. Quality Control Compromises: Allowing companies without the requisite expertise to manufacture patented drugs can lead to compromised quality control. Without strict regulations and oversight, the safety and efficacy of these medications may be jeopardized, posing serious health risks to consumers. 2. Proliferation of Counterfeits: With increased access to patented drug formulas, there's a heightened risk of counterfeit medications flooding the market. These counterfeit drugs not only lack the necessary efficacy but can also contain harmful substances, further endangering public health. 3. Undermining Innovation Incentives: Patent protection serves as a crucial incentive for pharmaceutical innovation. By diluting patent rights and allowing widespread generic manufacturing, we risk stifling future advancements in drug development, ultimately limiting treatment options for patients in need. 4. Regulatory Challenges: The proliferation of generic drug manufacturing without proper oversight can pose significant regulatory challenges. Ensuring compliance with safety standards and monitoring the quality of medications becomes increasingly difficult in a fragmented manufacturing landscape. In our pursuit of affordability, we must tread carefully to avoid compromising safety and innovation in the pharmaceutical industry. Let's prioritize robust regulatory frameworks and strategic approaches to pricing that balance accessibility with quality and innovation. 💡💼 #PharmaceuticalIndustry #DrugSafety #PublicHealthConcerns #IPR #intellectualproperty #medicine #pharma #counterfeit Kanchan Lele #indianlawyers #corporatelaw

🚨 Unveiling the Dark Side: The Hidden Dangers of Counterfeit Meds! 💊✖️ Enter Ritesh, lured by an online medicine deal that seemed too good to be true. Little did he know, this seemingly great deal would spiral into a health crisis, all thanks to counterfeit medicine born out of #IntellectualProperty Infringement. As Ritesh eagerly anticipated relief, the counterfeit pills, lacking the meticulously researched formula of their authentic counterparts, proved not only ineffective but perilous. His health took a hit, compounded by severe side effects from undisclosed, harmful substances. This cautionary tale isn't just a narrative; it's a stark reminder of the profound impact of intellectual property on our well-being. Authentic pharmaceuticals are the result of rigorous testing and innovation safeguarded by intellectual property rights. Counterfeits, however, pose a severe threat, jeopardizing lives and shaking trust in the healthcare system. Our world face a huge problem of #Counterfeit Medicine. Let's amplify awareness about the high stakes of counterfeits and underscore the paramount importance of intellectual property in preserving our health and safety. COPYKITTEN can help curb this problem with the help of your supply chain and customers. Let's connect to secure the Intellectual Properties. #medicine #b2b #b2bbusiness #corporatelaw #indianlawyer #IPR Vincent Jose Kanchan Lele #copykitten #lawyersoflinkedin #technologysolutions #fake #real #genuine #brandprotection

Back in 2022, Pfizer extends a lifeline to underserved communities by offering patented drugs at affordable prices, paving the way for equitable healthcare access worldwide. #copykitten #instaquest Kanchan Lele #pfizer #medicine #patent #ipr #intellectualproperty

Empower your supply chain and eleminate counterfeits with COPYKITTEN #copykitten #intellectualproperty #ipr #counterfeits #medicine #pharma #emcure #sharktank Kanchan Lele #patent #copyright